SR9009 [Ligand Id: 8901] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL1961796
  • Liver X receptor-α/LXR-alpha in Human [ChEMBL: CHEMBL2808] [GtoPdb: 602] [UniProtKB: Q13133]
There should be some charts here, you may need to enable JavaScript!
  • Rev-Erb-α/Nuclear receptor subfamily 1 group D member 1 in Human [ChEMBL: CHEMBL1961783] [GtoPdb: 596] [UniProtKB: P20393]
There should be some charts here, you may need to enable JavaScript!
  • Rev-Erb-β/Nuclear receptor subfamily 1 group D member 2 in Human [ChEMBL: CHEMBL1961784] [GtoPdb: 597] [UniProtKB: Q14995]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
Liver X receptor-α/LXR-alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2808] [GtoPdb: 602] [UniProtKB: Q13133]
ChEMBL Binding affinity to LXRalpha (unknown origin) by radioligand displacement assay B 5.2 pIC50 6300 nM IC50 J Med Chem (2013) 56: 4729-4737 [PMID:23656296]
Rev-Erb-α/Nuclear receptor subfamily 1 group D member 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1961783] [GtoPdb: 596] [UniProtKB: P20393]
ChEMBL Dissociation constant for binding to REV-ERB-alpha by circular dichroism B 6.1 pKd 800 nM Kd Nature (2012) 485: 62-68 [PMID:22460951]
ChEMBL REV-ERB-alpha mediated transcriptional suppression at Bmal1 promoter in HEK293 cell reporter assay F 6.15 pIC50 710 nM IC50 Nature (2012) 485: 62-68 [PMID:22460951]
GtoPdb - - 6.17 pIC50 670 nM IC50 Nature (2012) 485: 62-8 [PMID:22460951]
ChEMBL Increased REV-ERB-alpha LBD dependent repressor activity in HEK293 cell reporter assay B 6.17 pIC50 670 nM IC50 Nature (2012) 485: 62-68 [PMID:22460951]
ChEMBL Agonist activity at Rev-Erbalpha expressed in HEK293 cells coexpressing Gal4 ligand binding domain assessed as inhibition of transcription after 24 hrs by dual-Glo luciferase assay B 6.17 pIC50 670 nM IC50 Bioorg Med Chem Lett (2012) 22: 4413-4417 [PMID:22633688]
ChEMBL Agonist activity at biotinylated REV-ERBalpha (unknown origin) assessed as increase in biotinylated NCOR peptide recruitment after 1 hr by FRET assay B 4.3 pEC50 >50000 nM EC50 J Med Chem (2013) 56: 4729-4737 [PMID:23656296]
ChEMBL Agonist activity at Rev-Erbalpha expressed in HEK293 cells coexpressing BamII promoter assessed as repression of transcription after 24 hrs by dual-Glo luciferase assay F 6.15 pEC50 700 nM EC50 Bioorg Med Chem Lett (2012) 22: 4413-4417 [PMID:22633688]
ChEMBL Agonist activity at Rev-Erb alpha (unknown origin) by FRET assay B 6.21 pEC50 620 nM EC50 Bioorg Med Chem Lett (2020) 30: 127395-127395 [PMID:32738989]
Rev-Erb-β/Nuclear receptor subfamily 1 group D member 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1961784] [GtoPdb: 597] [UniProtKB: Q14995]
ChEMBL Increased REV-ERB-beta LBD dependent repressor activity in HEK293 cell reporter assay B 6.1 pIC50 800 nM IC50 Nature (2012) 485: 62-68 [PMID:22460951]
GtoPdb - - 6.1 pIC50 800 nM IC50 Nature (2012) 485: 62-8 [PMID:22460951]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]